Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T3CP
|
|||
| Former ID |
DNC006383
|
|||
| Drug Name |
N-oleoyl-O-(2-hydroxyethyl)hydroxylamine
|
|||
| Synonyms |
CHEMBL208270; N-oleoyl-O-(2-hydroxyethyl)hydroxylamine; BDBM50185033
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H39NO3
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)NOCCO
|
|||
| InChI |
1S/C20H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-24-19-18-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9-
|
|||
| InChIKey |
NPPFEZUZEVDUDA-KTKRTIGZSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. J Med Chem. 2006 Apr 6;49(7):2333-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.